Fixed-ratio combination of basal insulin and GLP-1 receptor agonist: is two better than one?

被引：1
|
作者：
Del Prato, Stefano [1 ]
机构：
[1] Univ Pisa, Dept Clin & Expt Med, Sect Diabet & Metab Dis, I-56124 Pisa, Italy
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2014年 / 2卷 / 11期
关键词：
D O I：
10.1016/S2213-8587(14)70185-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：856 / 858
页数：4
相关论文
共 50 条
  • [31] GLP-1 receptor agonist use during hospitalisation: Better glycaemic control compared to premixed insulin
    Jervis, Morgan
    Mitchell, Antonine Pineau
    Islam, Nafseen
    Mustafa, Omar G.
    Kelly, Philip A.
    Whyte, Martin B.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2022, 38 (08)
  • [32] Xultophy®: first fixed ratio basal insulin/GLP-1 analogue in a same pre-filled pen
    Schmidt, Barbara Coquard
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2017, 21 (1-2): : 43 - 43
  • [33] GLP-1 receptor agonists and basal insulin in type 2 diabetes
    Young, Laura A.
    Buse, John B.
    LANCET, 2014, 384 (9961): : 2180 - 2181
  • [34] Real-world study of the concomitant use of biphasic insulin as part 30/70 with GLP-1 receptor agonist versus first-generation basal insulin with GLP-1 receptor agonist in type 2 diabetes
    Davies, Melanie
    Alibegovic, Amra Ciric
    Anil, Gayathri
    Braae, Uffe Christian
    Jensen, Anders Boeck
    Nordsborg, Rikke Baastrup
    DIABETIC MEDICINE, 2024, 41 (05)
  • [35] Meta-Analysis of the Efficacy and Adverse Effects of a Fixed-Ratio Combination of Basal Insulin and GLP-1RA in T2DM Patients
    Gao, Xueying
    Cai, Xiaoling
    Ji, Linong
    DIABETES, 2017, 66 : A304 - A304
  • [36] Fixed versus flexible combination of GLP-1 receptor agonists with basal insulin in type 2 diabetes: A retrospective multicentre comparative effectiveness study
    Morieri, Mario Luca
    Rigato, Mauro
    Frison, Vera
    Simioni, Natalino
    D'Ambrosio, Michele
    Tadiotto, Federica
    Paccagnella, Agostino
    Lapolla, Annunziata
    Avogaro, Angelo
    Fadini, Gian Paolo
    DIABETES OBESITY & METABOLISM, 2019, 21 (11): : 2542 - 2552
  • [37] Insulin requirements after switching from GLP-1 receptor agonist to dual GIP/GLP-1 receptor agonist in patients with type 2 diabetes mellitus
    Lahey, Alexa M.
    Duprey, Karolyn
    Montague, Riley C.
    Schadler, Aric D.
    Naseman, Kristina W.
    PHARMACOTHERAPY, 2025,
  • [38] GLP-1 Receptor Agonist (GLP1ra) and Insulin Efficacy in Primary Health Care
    Hall, Gillian C.
    Mcmahon, Alex D.
    Dain, Marie-Paule
    Wang, Edward
    Home, Philip D.
    DIABETES, 2012, 61 : A276 - A276
  • [39] Combination therapy with GLP-1 receptor agonist and SGLT2 inhibitor
    DeFronzo, Ralph A.
    DIABETES OBESITY & METABOLISM, 2017, 19 (10): : 1353 - 1362
  • [40] Titratable Fixed-Ratio Combinations in Type 2 Diabetes Mellitus: Focus on GLP-1R Agonists Combined With Basal Insulin
    LaSalle, James
    White, John R., Jr.
    JOURNAL OF FAMILY PRACTICE, 2017, 66 (04): : S28 - S33
12345